undamentalytics Newsletter
Sign in

Varex Imaging Corp balance sheet

At the end of fiscal 2025, Varex Imaging Corp had total assets of $1.11bn, total liabilities of $621m and shareholders' equity of $473m. It held $145m in cash against $370m of debt: net debt of $225m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2015Oct 20152016Sept 20162017Sept 20172018Sept 20182019Sept 20192020Oct 20202021Oct 20212022Sept 20222023Sept 20232024Sept 20242025Oct 2025LTMJul 2026
Cash and equivalents21378352301011458915316914599
Receivables—122164154141124155173164158157145
Inventory—197235235248272225303278265299347
Total current assets—360495458438522554610658650642633
Goodwill—75242244291293292285289291198198
Total assets—6221,0409881,0391,1401,1481,1841,2501,2141,1071,100
Accounts payable—4259665873597865597084
Deferred revenue (current)—12111411997108139
Total current liabilities—78152152175161167173163196187187
Short-term debt—0202531332246218
Long-term debt—0464365364453432412441397366329
Total debt00494398401511481450448447370347
Total liabilities—86650549580674651638669670621590
Shareholders' equity496526379426445452483533568529473497
Net debt (negative = net cash)−21−37411346371411336360295278225248
Shares outstanding——38m38m38m39m39m40m41m41m42m42m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: INSP vs VREXATEC vs VREXOFIX vs VREX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Varex Imaging Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Varex Imaging Corp.